Judgment of the Court (Grand Chamber) of 25 July 2018
Teva UK Ltd and Others v Gilead Sciences Inc.
Request for a preliminary ruling from the High Court of Justice (England & Wales), Chancery Division (Patents Court)
Reference for a preliminary ruling — Medicinal products for human use — Treatment of human immunodeficiency virus (HIV) — Originator medicines and generic medicines — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3(a) — Conditions for obtaining — Concept of a ‘product protected by a basic patent in force’ — Criteria for assessment
Case C-121/17
Reports of Cases
published in the electronic Reports of Cases (Court Reports - general)
Links to the texts
|
Curia |
EUR-Lex |
Autres Liens |
Opinion
ECLI:EU:C:2018:278 |
|
|
|
Judgment
ECLI:EU:C:2018:585 |
|
|
|